Interpretation of Spirometry, Peak Flow, and Provocation Testing for Asthma.

Asthma Bronchodilator testing Bronchoprovocation testing Fractional exhaled nitric oxide Peak flow Spirometry

Journal

Otolaryngologic clinics of North America
ISSN: 1557-8259
Titre abrégé: Otolaryngol Clin North Am
Pays: United States
ID NLM: 0144042

Informations de publication

Date de publication:
26 Dec 2023
Historique:
medline: 28 12 2023
pubmed: 28 12 2023
entrez: 27 12 2023
Statut: aheadofprint

Résumé

Spirometry plays a crucial role in the diagnosis of asthma. The hallmark spirometry finding of expiratory airflow variability can be demonstrated in several ways including peak airflow and bronchodilator and bronchoprovocation testing. Challenges of overdiagnosis and underdiagnosis underscore the need to consider clinical context while interpreting these tests. A meticulous and multifaceted approach prioritizing objective testing is imperative while diagnosing asthma.

Identifiants

pubmed: 38151386
pii: S0030-6665(23)00199-8
doi: 10.1016/j.otc.2023.12.001
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2023 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Disclosure This work was supported by NIH (P30027482-14 and 1K08HL1 to GMS).

Auteurs

Sukhmani Boparai (S)

UAB Division of Pulmonary, Allergy, and Critical Care Medicine, University of Alabama at Birmingham, Pulmonary and Critical Care Medicine, 1900 University Boulevard, THT 422, Birmingham, AL 35294, USA.

George M Solomon (GM)

UAB Division of Pulmonary, Allergy, and Critical Care Medicine, University of Alabama at Birmingham, Pulmonary and Critical Care Medicine, 1900 University Boulevard, THT 422, Birmingham, AL 35294, USA; UAB Adult PCD and Bronchiectasis Programs; UAB CF Therapeutics Development Network Center; Gregory Fleming James CF Research Center, Birmingham, AL, USA. Electronic address: gsolomon@uabmc.edu.

Classifications MeSH